Clinical Trial Update: Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions

View source ↗

Summary

This study is recruiting to develop tumor organoids from undifferentiated carcinoma to guide personalized therapy decisions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Undifferentiated Carcinoma

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Undifferentiated Carcinoma | Status: RECRUITING